CR
Carmelo RIZZARI
University of Milano-Bicocca
Research areas: Medicine · Hematology · Acute Lymphoblastic Leukemia research · Acute Myeloid Leukemia Research · Lymphoma Diagnosis and Treatment
0000-0002-4828-3893
Employment
-
University of Milano-Bicocca Professor2020 - Present
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (164)
- Evaluating the Role of Anti-PEG Antibodies in Hypersensitivity to PEG-Asparaginase Through Clinically Relevant Cut-Points Defined by ELISA and Surface Plasmon Resonance Save
- The interplay of inborn errors of immunity with hematology – Report of the joint focus meeting of ESID, EHA, and SIOPE, Vienna, Austria Save
- Successful Treatment of Multirefractory Immune Thrombocytopenia in Rubinstein–Taybi Syndrome With Combined Rituximab and Eltrombopag Save
- Correction: Pourroy et al. High-Dose Methotrexate at All Ages: Safety, Efficacy, and Outcomes from the HDMTX European Registry. Cancers 2026, 18, 124 Save
- Blinatumomab consolidation in children with high-risk first-relapse B-cell precursor acute lymphoblastic leukemia: final 5-year follow-up analysis of a randomized multicenter phase 3 study Save
- High-Dose Methotrexate at All Ages: Safety, Efficacy, and Outcomes from the HDMTX European Registry Save
- Italian expert consensus recommendations for the safe administration of high-dose methotrexate in children with cancer and for the use of glucarpidase to manage delayed methotrexate elimination and/or high-dose methotrexate-induced acute kidney injury Save
- PEGylated Asparaginase in Children with Acute Lymphoblastic Leukemia Treated within the AIEOP-BFM ALL 2009 Trial: Population Pharmacokinetics and Drug Exposure Save
- Reply to: Methotrexate toxicity and glucarpidase: A call for dose optimization. Koppen A, et al. Br J Clin Pharmacol. 2025;91(5):1289‐1292 doi:10.1002/bcp.70044 Save
- The Healthcare Professionals’ and Patient Advocates’ Perspectives on the Care for Children with Cancer in Europe—A Report from the ESCALIER Project Save
- Prenatal origin of NUTM1 gene rearrangement in infant B‐cell precursor acute lymphoblastic leukaemia Save
- A European consensus recommendation on the management of delayed methotrexate elimination: supportive measures, leucovorin rescue and glucarpidase treatment Save
- Demographic Analysis of Cancer Research Priorities and Treatment Correlations Save
- Early intervention is important when administering glucarpidase for methotrexate intoxication Save
- Aligning Cancer Research Priorities in Europe with Recommendations for Conquering Cancer: A Comprehensive Analysis Save
- A Delphi study to determine the epidemiology and clinical management of patients treated with HDMTX who develop methotrexate (MTX) delayed elimination in France, Germany, Italy, and the UK Save
- The long-term efficacy and safety of nilotinib in pediatric patients with CML: a 5-year update of the DIALOG study Save
- Reply to: Comment on: A pooled subgroup analysis of glucarpidase treatment in 86 pediatric, adolescent, and young adult patients receiving high‐dose methotrexate therapy in open‐label trials Save
- Mobilising Collaboration among Stakeholders to Optimise the Growing Potential of Data for Tackling Cancer Save
- A pooled subgroup analysis of glucarpidase treatment in 86 pediatric, adolescent, and young adult patients receiving high‐dose methotrexate therapy in open‐label trials Save